Skip to main content

Agentic AI in Healthcare Market: The 35-40% Growth Forecast and How It Will Revolutionize Healthcare Diagnostics by 2030

 


The global agentic AI in healthcare market is set to witness a growth rate of 35-40% in the next 5 years. Increasing demand for personalized healthcare solutions; rapid advances in AI technology; healthcare industry’s growing shift toward preventive care; and integration of AI in diagnostics are some of the key factors driving the agentic AI in healthcare market. 

Agentic AI in healthcare refers to autonomous artificial intelligence systems capable of making independent decisions and performing tasks without requiring human intervention. These systems are designed to analyze complex medical data, predict outcomes, and provide recommendations or actions in real-time. Unlike traditional AI, agentic AI goes beyond providing insights to executing decisions, such as optimizing treatment plans, managing resources, or conducting precision diagnostics. Its applications span personalized medicine, diagnostics, drug discovery, and remote patient management. By leveraging advanced algorithms and machine learning, agentic AI aims to enhance efficiency, accuracy, and accessibility in healthcare, addressing workforce shortages and improving patient outcomes. 

Want to explore key trends, opportunities, and challenges in the agentic AI in healthcare market? 

Download a free sample report now 👉 https://meditechinsights.com/agentic-ai-in-healthcare-market/request-sample/ 

Increasing demand for personalized healthcare solutions to propel market demand 

The increasing demand for personalized healthcare solutions is a key driver for the Agentic AI in healthcare market. Personalized care requires tailored treatment plans based on an individual’s genetic, environmental, and lifestyle factors. Agentic AI, with its autonomous decision-making capabilities, processes vast datasets to identify unique patient needs, predict disease risks, and recommend precise therapies. This technology enables healthcare providers to move beyond one-size-fits-all approaches, improving treatment outcomes and patient satisfaction. As chronic diseases and genetic research grow, the ability of Agentic AI to deliver real-time, patient-specific insights is fueling its adoption across healthcare systems globally. 

Rapid advances in AI technology are driving the market growth 

Rapid advances in AI technology are significantly driving the growth of the Agentic AI in healthcare market. Innovations in machine learning algorithms, natural language processing, and deep learning enable these systems to process and analyze complex medical data with unprecedented accuracy and speed. Enhanced computational power and access to big data are further empowering Agentic AI to provide real-time decision-making and predictive insights in healthcare. These technological advancements facilitate applications like precision diagnostics, personalized medicine, and automated workflows, improving efficiency and patient outcomes. As AI capabilities continue to evolve, their integration into healthcare systems accelerates market expansion. 

Agentic AI in Healthcare Market: Competitive Landscape Analysis 

The global agentic AI in healthcare market is marked by the presence of established and emerging market players such as Microsoft Corporation; NVIDIA Corporation; Amazon Web Services, Inc.; IBM Corporation; Google DeepMind; GE HealthCare; OpenAI; Hippocratic AI Inc.; Automation Anywhere, Inc.; Genie AI Ltd.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion. 

Download a sample report for in-depth competitive insights https://meditechinsights.com/agentic-ai-in-healthcare-market/request-sample/ 

Global Agentic AI in Healthcare Market Segmentation

This report by Medi-Tech Insights provides the size of the global agentic AI in healthcare market at the regional- and country-level from 2023 to 2030. The report further segments the market based on Offering, application, and, end user.

  • Market Size & Forecast (2023-2030), By Offering, USD Million
    • Software
    • Services
  • Market Size & Forecast (2023-2030), By Application, USD Million
    • Patient Monitoring
    • Chronic Disease Management
    • Diagnostics
    • Clinical Decision Support
    • Administrative Workflow Automation
    • Virtual Health Assistants
    • Drug Discovery and Development
    • Personalized Healthcare
    • Medical and Patient Data Management
    • Others
  • Market Size & Forecast (2023-2030), By End User, USD Million
    • Healthcare Providers
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Healthcare Payers
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

 

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...
Post a Comment
Read more